195 related articles for article (PubMed ID: 20561917)
1. Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin.
Ito I; Kadowaki S; Tanabe N; Haruna A; Kase M; Yasutomo Y; Tsukino M; Nakai A; Matsumoto H; Niimi A; Chin K; Ichiyama S; Mishima M
Pulm Pharmacol Ther; 2010 Oct; 23(5):403-10. PubMed ID: 20561917
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
[TBL] [Abstract][Full Text] [Related]
3. Retrospective investigation of the clinical effects of tazobactam/piperacillin and sulbactam/ampicillin on aspiration pneumonia caused by Klebsiella pneumoniae.
Tsukada H; Sakai K; Cho H; Kimura Y; Tetsuka T; Nakajima H; Ito K
J Infect Chemother; 2012 Oct; 18(5):715-21. PubMed ID: 22460828
[TBL] [Abstract][Full Text] [Related]
4. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
5. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
Dietrich ES; Schubert B; Ebner W; Daschner F
Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection.
Erasmo AA; Crisostomo AC; Yan LN; Hong YS; Lee KU; Lo CM
Asian J Surg; 2004 Jul; 27(3):227-35. PubMed ID: 15564167
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Jaccard C; Troillet N; Harbarth S; Zanetti G; Aymon D; Schneider R; Chiolero R; Ricou B; Romand J; Huber O; Ambrosetti P; Praz G; Lew D; Bille J; Glauser MP; Cometta A
Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
[TBL] [Abstract][Full Text] [Related]
10. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Schmitt DV; Leitner E; Welte T; Lode H
Infection; 2006 Jun; 34(3):127-34. PubMed ID: 16804655
[TBL] [Abstract][Full Text] [Related]
13. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study.
Oi I; Ito I; Tanabe N; Konishi S; Hamao N; Yasutomo Y; Kadowaki S; Hirai T
J Infect Chemother; 2020 Feb; 26(2):181-187. PubMed ID: 31473111
[TBL] [Abstract][Full Text] [Related]
14. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Joshi M; Metzler M; McCarthy M; Olvey S; Kassira W; Cooper A
Respir Med; 2006 Sep; 100(9):1554-65. PubMed ID: 16487695
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital.
Saltoglu N; Dalkiran A; Tetiker T; Bayram H; Tasova Y; Dalay C; Sert M
Clin Microbiol Infect; 2010 Aug; 16(8):1252-7. PubMed ID: 19832720
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of therapy for aspiration pneumonia with imipenem/cilastatin sodium].
Kikuchi N; Onozaki I; Kohno N; Yamaguchi T; Nagao K; Kuriyama T; Kanno H; Kubo S; Tatsumi K; Okita S
Jpn J Antibiot; 1990 Jan; 43(1):23-30. PubMed ID: 2112207
[TBL] [Abstract][Full Text] [Related]
17. [Domestic imipenem cilastatin sodium for the treatment of severe aspiration pneumonia, a curative effect observation].
Yin HY; Ye XL; Zhang R; Zhu YF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Oct; 24(10):628-31. PubMed ID: 23040783
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Pillay T; Pillay DG; Adhikari M; Sturm AW
Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
Figuera A ; Rivero N; Pajuelo F; Font P; Leyra F; de La Cámara R; Arranz R; María Fernández Rañada J
Med Clin (Barc); 2001 May; 116(16):610-1. PubMed ID: 11412645
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
